Driving the Use of Biomarker-Based Enrollment in GBM trials to Accelerate Clinical Success & Improve Patient Outcomes
- Addressing the lack of analysis of molecular data in current enrolment protocols for GBM trials
- Discussing strategies to incorporate biomarker-based enrolment given the rise of personalized therapies
- Establishing the efficacy of targeted treatments in recurrent GBM to accelerate the delivery of peronalized therapies